Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection.
Gay CL, Kuruc JD, Falcinelli SD, Warren JA, Reifeis SA, Kirchherr JL, James KS, Dewey MG, Helms A, Allard B, Stuelke E, Gamble A, Plachco A, Gorelick RJ, Eron JJ, Hudgens M, Garrido C, Goonetilleke N, DeBenedette MA, Tcherepanova IY, Nicolette CA, Archin NM, Margolis DM.
Gay CL, et al. Among authors: hudgens m.
Sci Rep. 2020 Mar 20;10(1):5134. doi: 10.1038/s41598-020-61878-3.
Sci Rep. 2020.
PMID: 32198428
Free PMC article.